SANARA MEDTECH INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.06 USD | +14.07% |
|
+3.65% | -17.13% |
| May. 14 | Transcript : Sanara MedTech Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| May. 13 | Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down | MT |
Presentation Operator MessageOperator (Operator)Greetings. Welcome to the Sanara MedTech Inc. ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. It markets several products for surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products, CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus Advanced Viable Bone Matrix (ALLOCYTE Plus), BIASURGE, FORTIFY TRG Tissue Repair Graft (FORTIFY TRG), and FORTIFY FLOWABLE Extracellular Matrix (FORTIFY FLOWABLE) are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. CellerateRX Surgical products, TEXAGEN products, FORTIFY TRG and FORTIFY FLOWABLE are used in specialties, including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and others.
Sector
Pharmaceuticals
Calendar
2024-06-12
- Annual General Meeting
Related indices
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
29.86
USD
Average target price
44
USD
Spread / Average Target
+47.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -17.13% | 258M | |
| +31.37% | 588B | |
| -2.60% | 364B | |
| +20.83% | 326B | |
| +5.69% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +10.77% | 167B | |
| +0.10% | 161B |
- Stock Market
- Equities
- SMTI Stock
- News Sanara MedTech Inc.
- Transcript : Sanara MedTech Inc., Q4 2023 Earnings Call, Mar 26, 2024
